113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details
臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01970735 (ClinicalTrials.gov) | October 2013 | 23/10/2013 | Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 | Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 | Muscular Dystrophy, Facioscapulohumeral | Biological: Blood test | Centre Hospitalier Universitaire de Nice | NULL | Recruiting | 18 Years | 75 Years | Both | 100 | N/A | France |